36E79724D0002
Indefinite Delivery Contract
Overview
Government Description
NEW AWARD FOR RANIBIZUMAB (BYOOVIZ) VIALS WITH BIOGEN U.S. CORPORATION. PERIOD OF PERFORMANCE IS 12/23/23 TO
12/22/24 WITH FOUR ONE-YEAR OPTIONS.
Awardee
Awarding / Funding Agency
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Multiple / Single Award
Single Award
Who Can Use
Multiple Agencies
Vehicle Ceiling
$11,392,063 (0% Used)
Related Opportunity
Analysis Notes
Amendment Since initial award the Ordering Period End Date was extended from 12/22/24 to 12/22/25.
Subcontracting Plan This IDC has a Commercial Subcontract Plan. The Department of Veterans Affairs has an overall 2023 small business subcontracting goal of 17%
Subcontracting Plan This IDC has a Commercial Subcontract Plan. The Department of Veterans Affairs has an overall 2023 small business subcontracting goal of 17%
Biogen U.S. Corporation was awarded
Indefinite Delivery Contract 36E79724D0002 (36E797-24-D-0002)
by
National Acquisition Center
for New Award For Ranibizumab (BYOOVIZ) Vials With Biogen U.S. Corporation. Period Of Performance Is 12/23/23 To
12/22/24 With Four One-Year Options.
in December 2023.
The IDC
has a duration of 2 years and
was awarded
through solicitation Ranibizumab
full & open
with
NAICS 325412 and
PSC 6505
via direct negotiation acquisition procedures with 3 bids received.
The total ceiling is $11,392,063, of which 0% has been used.
Status
(Open)
Modified 1/31/25
Period of Performance
12/22/23
Start Date
12/22/25
Ordering Period End Date
Task Order Obligations
$0
Total Obligated
$0
Current Award
$0
Potential Award
Opportunity Lifecycle
Procurement history for 36E79724D0002
Transaction History
Modifications to 36E79724D0002
People
Suggested agency contacts for 36E79724D0002
Competition
Number of Bidders
3
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Commercial Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
E82LHNZSCUA3
Awardee CAGE
6M2Q6
Agency Detail
Awarding Office
36E797 NAC PHARMACEUTICALS (36E797)
Funding Office
36E797 NAC PHARMACEUTICALS (36E797)
Created By
raymond.roldan@va.gov
Last Modified By
nicholas.mcgregor@va.gov
Approved By
nicholas.mcgregor@va.gov
Legislative
Legislative Mandates
None Applicable
Awardee District
MA-07
Senators
Edward Markey
Elizabeth Warren
Elizabeth Warren
Representative
Ayanna Pressley
Last Modified: 1/31/25